The National Health Insurance Authority (NHIA) says it plans to review medicine tariffs in response to the significant rise in medical inflation experienced over the past few months in Nigeria.
NHIA Director-general and Chief Executive Officer, Dr. Kelechi Ohiri, disclosed this to newsmen in Abuja on Monday.
He said the initiative is part of a broader strategy to ensure the affordability, quality, and sustainability of medicines under the national health insurance programme.
“The aim is to address one of the critical barriers to accessing high-quality healthcare, which is the cost of medicines,” Ohiri said.
He reiterated that the authority’s proactive measure reflects its dedication to improving healthcare access and affordability for all citizens.
Ohiri further highlighted the launch of a medicine initiative designed to guarantee the long-term sustainability and affordability of essential drugs.
This initiative aims to combat the effects of medical inflation and ensure that the health insurance program remains viable and effective for the future.
Acknowledging the challenges posed by medical inflation and the need for sustainable healthcare financing, Ohiri said by reviewing and adjusting medicine tariffs, NHIA aims to alleviate the financial burden on patients and ensure that quality care remains accessible.
